This wiki has undergone a migration to Confluence found Here
<meta name="googlebot" content="noindex">

Difference between revisions of "20170110 US Realm SC Call"

From HL7Wiki
Jump to navigation Jump to search
Line 37: Line 37:
 
===============================================================================--->
 
===============================================================================--->
 
|-
 
|-
| || Calvin Beebe || ||Keith Boone|| || Hans Buitendijk
+
| || Calvin Beebe || ||Keith Boone||Regrets || Hans Buitendijk
 
|-
 
|-
 
| ||Lorraine Constable || ||Johnathan Coleman|| ||Ed Hammond
 
| ||Lorraine Constable || ||Johnathan Coleman|| ||Ed Hammond
Line 49: Line 49:
 
|  ||Sandra Stuart||. ||Pat Van Dyke||. || Anne Wizauer
 
|  ||Sandra Stuart||. ||Pat Van Dyke||. || Anne Wizauer
 
|-
 
|-
|  ||Danielle Friend||. ||Eric Haas||. || Jenni Syed
+
|  ||Danielle Friend||. ||Eric Haas||Regrets || Jenni Syed
 
|-
 
|-
 
|  ||Steve Posnak||. ||David Susanto||. ||  
 
|  ||Steve Posnak||. ||David Susanto||. ||  

Revision as of 17:31, 10 January 2017

back to US_Realm_Steering_Committee
back to US_Realm_Steering_Committee_Conference_Calls

US Realm Steering Committee Call Agenda/Minutes

Location: call 770-657-9270 using code 156896#
929-752-237

Date: 2017-01-10
Time: 1 PM Eastern
Co-Chairs Ed/Brett Note taker(s) Anne
Attendee / Name
Calvin Beebe Keith Boone Regrets Hans Buitendijk
Lorraine Constable Johnathan Coleman Ed Hammond
Tony Julian Paul Knapp Austin Kreisler
Brett Marquard Ken McCaslin Nancy Orvis
Brian Pech Wayne Kubick Mark Roche
Sandra Stuart . Pat Van Dyke . Anne Wizauer
Danielle Friend . Eric Haas Regrets Jenni Syed
Steve Posnak . David Susanto . Visitor / Name
no quorum definition

Agenda

Administrivia

  • UPDATED US Realm Meeting Day/Time for San Antonio: Tuesday, 7:00 am, Blanco Room
  • Agenda review
  • Review notes from 20161206_US_Realm_SC_Call
  • Review Items:
    • Project Approval Request from the OO WG of the SSD-SD of Newborn Dried Blood Spot Screening Lab Order Component/ Implementation Guide
  • Discussion:
    • Payer community representation on US Realm Steering Committee
    • Do we want to expand the scope of the FHIR US-Core? What is the process?
    • What US Realm FHIR IGs are we tracking? (this should probably be a recurring agenda item)
    • Who is providing coordination among those IGs?
    • Do we want to develop a list of principles for developing US Realm FHIR IGs?
      • Reuse us-core
      • Follow us realm extension development process
      • Quality criteria (see example SDWG use for C-CDA)

Minutes

Meeting Outcomes

Actions
Next Meeting/Preliminary Agenda Items


© 2017 Health Level Seven® International. All rights reserved